Cancer Epidemiology
Volume 34, Issue 1 , Pages 3-6 , February 2010

Contributions of leukocytes to tumor invasion and metastasis: The “piggy-back” hypothesis

  • Yan-gao Man

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Gynecologic and Breast Pathology Armed Forces Institute of Pathology and American Registry of Pathology, 6825 16th Street, NW, Washington DC, United States. Tel.: +1 202 782 1612; fax: +1 202 782 3939.
    • ,
  • Russell Harley
    • ,
  • Jeffrey Mason
    • ,
  • William A. Gardner

,Accepted 18 November 2009.

References 

  1. Clarke R, Brunner N, Katzenellenbogen BS. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc Natl Acad Sci USA. 1989;86:3649–3653
  2. Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG. Multistep carcinogenesis of breast cancer and tumor heterogeneity. J Mol Med. 1997;75:429–439
  3. Goldfarb RH, Liotta LA. Proteolytic enzymes in cancer invasion and metastasis. Semin Thromb Hemost. 1986;12:294–307
  4. Duffy MJ, Maguire TM, Hill A, McDermott E, O’Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2000;2:252–257
  5. Millis RR, Thynne GS. In situ intraduct carcinoma of the breast: a long term follow-up study. Br J Surg. 1975;62:957–962
  6. Goeman L, Joniau S, Ponette D, Van der Aa F, Roskams T, Oyen R, et al. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer. Prostate Cancer Prostatic Dis. 2003;6:305–310
  7. Page DL, Duppont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49:751–758
  8. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trial and tribulations. Science. 2002;295(5564):2387–2392
  9. Matrisian LM, Sledge GW, Mohla S. Exacellular proteolysis and cancer: meeting summary and future directions. Cancer Res. 2003;63:6105–6109
  10. Kasahara Y, Tsukada Y. New insights and future advances in cancer diagnostics: Limitations of conventional tumor markers. In:  Nakarnura RM,  Grody WW,  Wu JT,  Nagle RB editor. Cancer Diagnostics: Current and Future Trends. Totowa, NJ: Humanna Press; 2004;p. 15–26
  11. Warnberg F, Nordgren H, Bergkvist L, Hulmberg L. Tumor markers in breast carcinomas correlate with grade rather than with invasiveness. Br J Cancer. 2001;85:869–874
  12. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Nat Cancer Inst. 2004;96:906–920
  13. Zaugg K, Bodis S. Is there role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?. Radiother Oncol. 2000;55:95–99
  14. Gottlieb C, Raiu U, Greenwald KA. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions:an immunohistochemical study. Mod Pathol. 1990;3:35–140
  15. Guelstein VI, Tehypysheva TA, Ermilova VD, Liubimov AV. Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. In J Cancer. 1993;53:269–277
  16. Zhang R, Man YG, Vang RS, Saenger JS, Barner R, Wheeler D, et al. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res. 2003;5:R151–R156
  17. Man YG, Tai L, Barner R, Vang R, Saenger JS, Shekitka KM, et al. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res. 2003;5:R231–R241
  18. Man YG, Sang QXA. The significance of focal myoepitehlial cell layer disruptions in breast tumor invasion: a paradigm shift from the “protease-centered” hypothesis. Exp Cell Res. 2004;301:103–118
  19. Yousefi M, Mattu R, Gao C, Man YG. Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: implications for tumor progression and invasion. Appl Immunohistochem Mol Morphol. 2005;13:30–37
  20. Man YG, Shen T, Weisz J, Berg PE, Schwartz AM, Mulshine JL, et al. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev. 2005;29:323–331
  21. Man YG, Zhao CQ, Wang J. Breast tumor cell clusters and their budding derivatives show different immunohistochemical profiles during stromal invasion: implications for hormonal and drug therapies. Cancer Ther. 2006;4:193–204
  22. Man YG, Nieburgs HE. A subset of cell clusters with malignant features in morphologically normal and hyperplastic breast tissues. Cancer Detect Prev. 2006;30(3):239–247
  23. Man YG, Zhao CQ, Wang J, Chen XL. A subset of prostate basal cells lacks corresponding phenotypic markers. Pathol Res Pract. 2006;202(9):651–662
  24. Xu ZL, Wang W, Deng CX, Man YG. Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness. Int J Biol Sci. 2009;5(1):82–96
  25. Liu AJ, Wei LX, Gardner WA, Man YG. Correlated alterations in prostate basal cell layer and basement membrane. Int J Biol Sci. 2009;5:276–285
  26. Man YG, Zhang Y, Shen T, Vinh TN, Zeng X, Tauler J, et al. cDNA expression profiling identifies elevated expressions of tumor progression and invasion-related genes in cell clusters of in situ breast tumors. Breast Cancer Res Treat. 2005;89:199–208
  27. Zhang XC, Hashemi SS, Yousefi M, Gao CL, Sheng J, Mason J, et al. Atypical expression of c-erbB2 in cell clusters overlying focally disrupted breast myoepithelial cell layers: a potential sign for increasing cell motility and invasion. Int J Biol Sci. 2008;4:259–269
  28. Zhang XC, Hashemi SS, Yousefi M, Gao CL, Sheng J, Mason J, et al. Atypical expression of e-cadherin in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion. Pathol Res Pract. 2009;205:375–385
  29. Man YG, Shen T, Zhao YG, Sang QX. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: a potential mechanism for basal cell layer disruptions and tumor invasion. Cancer Detect Prev. 2005;29:161–169
  30. Man YG. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion. Med Hypotheses. 2007;69(6):1340–1357
  31. Man YG, Gardner WA. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Med Hypotheses. 2008;70:387–408
  32. Man YG, Gardner WA. Bad seeds produce bad crops: a single step-process of prostate carcinogenesis and progression. Int J Biol Sci. 2008;4:246–258
  33. Man YG. Bad seeds produce bad crops: a single step-process of breast carcinogenesis and progression. Biosci Hypotheses. 2008;1:147–155
  34. Pawelek JM, Chakraborty AK. The cancer cell–leukocyte fusion theory of metastasis. Adv Cancer Res. 2008;101:397–444
  35. Pawelek JM, Chakraborty AK. Fusion of tumor cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer. 2008;8(5):377–386
  36. Pawelek JM. Tumor cell fusion as a source of myeloid traits in cancer. Lancet Oncol. 2005;6(12):988–993
  37. Pawelek JM, Chakraborty A, Lazova R, Yilmaz Y, Cooper D, Brash D, et al. Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion?. In:  Dittmar T,  Zaenker KS, Schmidt  editor. Infection and Inflammation: Impacts on Oncogenesis. vol. 13:Basel: Karger; 2006;p. 138–155Contrib Microbiol
  38. Smith CJ, Gardner WA. Inflammation-proliferation: possible relationships in the prostate. Prog Clin Biol Res. 1987;239:317–325
  39. Gannot G, Gannot I, Vered H, Buchner A, Keisari Y. Increase in immune cell infiltration with progression of oral epithelium from hyperkeratiosis to dysplasia and carcinoma. Br J Cancer. 2002;86:1444–1448
  40. MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu P, Resnick MI, et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study. J Urol. 2006;176:1012–1016
  41. O’Brien J, Schedin P. Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer?. J Mammary Gland Biol Neoplasia. 2009;14(2):145–157
  42. Mathelin C, Annane K, Treisser A, Chenard MP, Tomasetto C, Bellocq JP, et al. Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res. 2008;28(4C):2447–2452
  43. Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, et al. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol. 2008;112(1):71–78
  44. Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer. 1997;72:720–727
  45. Peek RM, Mohla S, DuBois RN. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res. 2005;65:8583–8586

☆ The opinions and assertions contained herein represent the personal views of the authors and are not to be construed as official or as representing the views of the Department of the Army or the Department of Defense.

PII: S1877-7821(09)00172-6

doi: 10.1016/j.canep.2009.11.005

Cancer Epidemiology
Volume 34, Issue 1 , Pages 3-6 , February 2010

Article Tools